Kendall™ AMD Foam Discs

Antimicrobial Foam Discs

Kendall™ AMD Foam Discs

Kendall™ AMD antimicrobial foam discs are efficient, cost effective and compliant with most protocols.

Impregnated with 0.5% PHMB (Polyhexamethylene Biguanide), Kendall™ AMD antimicrobial foam disc provides an antimicrobial barrier to bacteria penetration through the dressing and prevents colonisation and proliferation of bacteria within the dressing for up to seven days.

Key benefits

Kendall™ AMD antimicrobial foam disc is a highly absorbent, antimicrobial, non-linting dressing designed specifically to protect and cushion exit sites.

  • Helps to protect against catheter related blood stream infections (CRBSI)
  • Protects insertion sites from harmful bacteria such as MRSA & VRE
  • Semi-occlusive allowing the exchange of gases such as oxygen and water vapour
  • Provides efficacy for up to 7 days
  • Limits cross contamination
  • Promotes a healthy wound (insertion) environment
  • Prevents and manages overgranulation around exit sites
  • Double sided for ease of application
  • Flexible nature allows it to conform easily to all body contours
  • Plus all the benefits of PHMB foam dressings[1]

 

 

References
[1] Evans, J. Exit site management in the community using KendallTM AMD antimicrobial foam dressing with PHMB. JCN 2014; 28(1): 55-58.

Kendall™ AMD Foam clinical studies

Author(s) Title Publication
Ashman, P. et al. Antimicrobial dressings testing – Foams SMTL, Wounds UK, 2013, poster View
Barrett, S. et al. Consensus document – PHMB and its potential contribution to wound management Wounds UK, 2010 View
Bowen, G. An evaluation of a foam dressing impregnated with 0.5% PHMB with the care pathway of the diabetic foot ulcer Wounds UK, 2009 View
Ciprandi, G. Using antimicrobial foam dressings in paediatric wounds Wounds International 2012, 3(2) View
De Boer, C. Managing moisture and bacterial burden in acute wounds EWMA, 2009
Hadaway, L. PHMB dressing – another promising tool to reduce catheter related bloodstream infection Journal of the Association of Vascular Access, 2011, 15(4) View
Hagelstein, S.M. et al. A series of case studies investigating the performance of a new antimicrobial foam dressing EWMA, 2009
Hucker, M. Different challenges – one solution Wounds UK, 2009
Johnson, S. and Leak, K. Evaluating a dressing impregnated with PHMB Wounds UK, 2011, 7(2) View
Kirker, K.R. et al. Efficacy of KendallTM AMD antimicrobial foam dressing against MRSA Wounds UK, 2009 View
Leak, K. et al. An evaluation of 4 patients post negative pressure wound therapy using a foam dressing containing 0.5% Polyhexamethyline Biguanide (PHMB) Wounds UK, 2009 View
Leak, K. et al. Managing the challenge of wound exudate EMWA, 2009 View
McGhee, D. et al. Activity of antimicrobial dressing using clinically relevant organisms MRSA, VRE and P. Aeruginosa Covidien Bioscience Laboratory, 2009 View
Mudge, E. et al. Pilot study comparing KendallTM AMD antimicrobial foam dressing with ALLEVYN Ag hydrocellular antimicrobial dressing in venous leg ulcers Wounds UK, 2014, 10(1) View
Neves, G. et al. Evaluating a foam dressing impregnated with 0.5% PHMB in the management of infected vascular ulcers EWMA, 2010 View
Shah, C.B. et al. Efficacy and mode of action of a new PHMB impregnated polyurethane foam dressing  Covidien, 2009 View
Sibbald, R.G. et al. Reduction of bacterial burden and pain in chronic wounds using a new PHMB antimicrobial foam dressing – clinical trial results Advances in Skin & Wound Care 2011, 24(2) View
Spruce, P. et al. AMD foam made easy Wounds International View
Stanway, S. et al. A review of a foam dressing containing 0.5% PHMB under compression therapy in the management of lower limb ulceration EWMA, 2010 View
Sterling, W. et al. Patient perceptions of a new antimicrobial dressing Wounds UK, 2009 View
Timmons, J. and Leak, K. PHMB: the role of KendallTM AMD antimicrobial foam dressing (0.5% PHMB) in the treatment of wounds Wounds UK Supplement, 2009 View
Warriner, L. and  Spruce, P. Managing overgranulation tissue around gastrostomy Sites British Journal of Nursing, 2012, 21(5) View

Kendall™ AMD antimicrobial foam discs are ideal dressings in the local management of exudate that may occur at surgically induced body exit sites such as:

  • Catheter insertions (e.g. central venous catheters and peripherally inserted central catheters)
  • Tracheostomy sites
  • External fixation devices
  • G-tubes or J-tubes
  • Penrose drains
  • Chest drains
  • Nephrostomy sites
  • Central venous lines
  • Suprapubic catheters

 

 

Applying Kendall AMD antimicrobial foam disc*

  1. Cleanse the wound in accordance with normal procedures
  2. Dry the surrounding skin thoroughly
  3. Prepare the site per local protocol
  4. Remove Kendall™ AMD antimicrobial foam disc dressing from package and place dressing around the percutaneous device
  5. The disc is not orientated and can be applied with either side down
  6. For easiest removal during dressing changes, align disc slit under the existing catheter (covering the perforation/slit with the catheter)
  7. Approximate perforation/slit edges for best efficiency
  8. Secure Kendall™ AMD antimicrobial foam disc dressing and percutaneous device with transparent dressing or other suitable securement dressing
  9. Change per local protocol and as needed for the excessive drainage. Kendall™ AMD antimicrobial foam disc is effective for up to 7 days

 

 

*See product insert leaflet for full instructions for use.

Size Pieces per box Product code NHS code
1″ (4mm hole) 10 55511AMDX ELA590
1″ (7mm hole) 10 55512AMDX ELA606